The first is known as hereditary transthyretin-mediated amyloidosis ... TTR is a protein that is made in the liver, brain, and retina of the eye. It helps to carry a thyroid hormone (thyroxine ...

The US Food and Drug Administration (FDA) has cleared OcuSciences’ retinal health assessment device, OcuMet Beacon. The non-invasive device is indicated for ophthalmoscope scanning for infrared ...

The full study, published in Science Translational Medicine on April 30, explains that a specific protein known as hypoxia-inducible factor (HIF) accumulates in certain cells in the retina during ...

"Dry AMD is driven by a number of factors that contribute to the death of retinal cells, leading to irreversible vision loss," stated Mary Hamby, PhD, vice president of research. "Preclinical ...

Analysis Presented at the Heart Failure 2025 Congress Supports Primary Findings, Highlighting Impact of AMVUTTRA, which Delivers Rapid Knockdown of Transthyretin – – Additional 42-Month Data ...

The activity of retina scan with the promise of hundreds of thousands of money has many impacts and risks. Citing Trustcloud.tech, biometric data is unique and cannot be changed, making it an ideal ...

The gene therapy, botaretigene sparoparvovec (bota-vec for short), was being evaluated as a treatment for X-linked retinal pigmentosa (XLRP). On the main goal of showing change in vision at one ...

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Lejla Vajzovic, MD, FASRS, shares pearls on delivery of subretinal gene therapy to treat common and ...

Edmon agreed that the entrance of retina data has the potential for misuse. "It should be banned, as in other countries, for a relatively safer option," he said to Tempo via messaging applications on ...

Alyftrek for the treatment of cystic fibrosis and Attrogy for the treatment of hereditary transthyretin (TTR)–mediated amyloidosis. Alyftrek, a combination of deutivacaftor, tezacaftor ...